Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Preclinical Imaging (In-VIVO) Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Preclinical Imaging (In-VIVO) Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Modality
      • 1.3.3 Reagent
      • 1.3.4 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Preclinical Imaging (In-VIVO) Market Share by Application (2019-2025)
      • 1.4.2 Oncology
      • 1.4.3 Cardio and Vascular
      • 1.4.4 Neurology
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Preclinical Imaging (In-VIVO) Production Value 2014-2025
      • 2.1.2 Global Preclinical Imaging (In-VIVO) Production 2014-2025
      • 2.1.3 Global Preclinical Imaging (In-VIVO) Capacity 2014-2025
      • 2.1.4 Global Preclinical Imaging (In-VIVO) Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Preclinical Imaging (In-VIVO) Market Size CAGR of Key Regions
      • 2.2.2 Global Preclinical Imaging (In-VIVO) Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Preclinical Imaging (In-VIVO) Capacity by Manufacturers
      • 3.1.2 Global Preclinical Imaging (In-VIVO) Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Preclinical Imaging (In-VIVO) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Preclinical Imaging (In-VIVO) Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Preclinical Imaging (In-VIVO) Market Concentration Ratio (CR5 and HHI)
    • 3.3 Preclinical Imaging (In-VIVO) Price by Manufacturers
    • 3.4 Key Manufacturers Preclinical Imaging (In-VIVO) Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Preclinical Imaging (In-VIVO) Market
    • 3.6 Key Manufacturers Preclinical Imaging (In-VIVO) Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Modality Production and Production Value (2014-2019)
      • 4.1.2 Reagent Production and Production Value (2014-2019)
      • 4.1.3 Others Production and Production Value (2014-2019)
    • 4.2 Global Preclinical Imaging (In-VIVO) Production Market Share by Type
    • 4.3 Global Preclinical Imaging (In-VIVO) Production Value Market Share by Type
    • 4.4 Preclinical Imaging (In-VIVO) Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Preclinical Imaging (In-VIVO) Consumption by Application

    6 Production by Regions

    • 6.1 Global Preclinical Imaging (In-VIVO) Production (History Data) by Regions 2014-2019
    • 6.2 Global Preclinical Imaging (In-VIVO) Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Preclinical Imaging (In-VIVO) Production Growth Rate 2014-2019
      • 6.3.2 United States Preclinical Imaging (In-VIVO) Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Preclinical Imaging (In-VIVO) Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Preclinical Imaging (In-VIVO) Production Growth Rate 2014-2019
      • 6.4.2 European Union Preclinical Imaging (In-VIVO) Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Preclinical Imaging (In-VIVO) Import & Export
    • 6.5 China
      • 6.5.1 China Preclinical Imaging (In-VIVO) Production Growth Rate 2014-2019
      • 6.5.2 China Preclinical Imaging (In-VIVO) Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Preclinical Imaging (In-VIVO) Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Preclinical Imaging (In-VIVO) Consumption by Regions

    • 7.1 Global Preclinical Imaging (In-VIVO) Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Preclinical Imaging (In-VIVO) Consumption by Type
      • 7.2.2 United States Preclinical Imaging (In-VIVO) Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Preclinical Imaging (In-VIVO) Consumption by Type
      • 7.3.2 European Union Preclinical Imaging (In-VIVO) Consumption by Application
    • 7.4 China
      • 7.4.1 China Preclinical Imaging (In-VIVO) Consumption by Type
      • 7.4.2 China Preclinical Imaging (In-VIVO) Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Preclinical Imaging (In-VIVO) Consumption by Type
      • 7.5.2 Rest of World Preclinical Imaging (In-VIVO) Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 PerkinElmer
      • 8.1.1 PerkinElmer Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Preclinical Imaging (In-VIVO)
      • 8.1.4 Preclinical Imaging (In-VIVO) Product Introduction
      • 8.1.5 PerkinElmer Recent Development
    • 8.2 Bruker Corporation
      • 8.2.1 Bruker Corporation Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Preclinical Imaging (In-VIVO)
      • 8.2.4 Preclinical Imaging (In-VIVO) Product Introduction
      • 8.2.5 Bruker Corporation Recent Development
    • 8.3 FUJIFILM Holdings
      • 8.3.1 FUJIFILM Holdings Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Preclinical Imaging (In-VIVO)
      • 8.3.4 Preclinical Imaging (In-VIVO) Product Introduction
      • 8.3.5 FUJIFILM Holdings Recent Development
    • 8.4 Mediso
      • 8.4.1 Mediso Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Preclinical Imaging (In-VIVO)
      • 8.4.4 Preclinical Imaging (In-VIVO) Product Introduction
      • 8.4.5 Mediso Recent Development
    • 8.5 MILabs B.V.
      • 8.5.1 MILabs B.V. Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Preclinical Imaging (In-VIVO)
      • 8.5.4 Preclinical Imaging (In-VIVO) Product Introduction
      • 8.5.5 MILabs B.V. Recent Development
    • 8.6 MR Solutions
      • 8.6.1 MR Solutions Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Preclinical Imaging (In-VIVO)
      • 8.6.4 Preclinical Imaging (In-VIVO) Product Introduction
      • 8.6.5 MR Solutions Recent Development
    • 8.7 Aspect Imaging
      • 8.7.1 Aspect Imaging Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Preclinical Imaging (In-VIVO)
      • 8.7.4 Preclinical Imaging (In-VIVO) Product Introduction
      • 8.7.5 Aspect Imaging Recent Development
    • 8.8 LI-COR Biosciences
      • 8.8.1 LI-COR Biosciences Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Preclinical Imaging (In-VIVO)
      • 8.8.4 Preclinical Imaging (In-VIVO) Product Introduction
      • 8.8.5 LI-COR Biosciences Recent Development
    • 8.9 Trifoil Imaging
      • 8.9.1 Trifoil Imaging Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Preclinical Imaging (In-VIVO)
      • 8.9.4 Preclinical Imaging (In-VIVO) Product Introduction
      • 8.9.5 Trifoil Imaging Recent Development
    • 8.10 Miltenyi Biotec
      • 8.10.1 Miltenyi Biotec Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Preclinical Imaging (In-VIVO)
      • 8.10.4 Preclinical Imaging (In-VIVO) Product Introduction
      • 8.10.5 Miltenyi Biotec Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Preclinical Imaging (In-VIVO) Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Preclinical Imaging (In-VIVO) Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Preclinical Imaging (In-VIVO) Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Preclinical Imaging (In-VIVO) Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Preclinical Imaging (In-VIVO) Production Forecast by Type
      • 9.7.2 Global Preclinical Imaging (In-VIVO) Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Preclinical Imaging (In-VIVO) Sales Channels
      • 10.2.2 Preclinical Imaging (In-VIVO) Distributors
    • 10.3 Preclinical Imaging (In-VIVO) Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      In 2019, the market size of Preclinical Imaging (In-VIVO) is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Preclinical Imaging (In-VIVO).

      This report studies the global market size of Preclinical Imaging (In-VIVO), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Preclinical Imaging (In-VIVO) production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      PerkinElmer
      Bruker Corporation
      FUJIFILM Holdings
      Mediso
      MILabs B.V.
      MR Solutions
      Aspect Imaging
      LI-COR Biosciences
      Trifoil Imaging
      Miltenyi Biotec

      Market Segment by Product Type
      Modality
      Reagent
      Others

      Market Segment by Application
      Oncology
      Cardio and Vascular
      Neurology
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Preclinical Imaging (In-VIVO) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Preclinical Imaging (In-VIVO) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Preclinical Imaging (In-VIVO) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now